I assume that the remaining 3 trials are also unblinded which means they will have access to data all the way through.
I’ll be watching the ‘body language’ and tone of Jon as we get closer to the release.
The only reason I see a takeover in the short term is if data is not reading as well as the first trial.
If the data is just as compelling there will not be any deal unless it’s a massive knockout deal.
I assume that the remaining 3 trials are also unblinded which...
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.70 |
Change
0.520(2.71%) |
Mkt cap ! $2.515B | |||
| Open | High | Low | Value | Volume |
| $19.39 | $19.84 | $19.28 | $5.675M | 288.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 1531 | $19.66 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.81 | 557 | 1 |
View Market Depth
| Last trade - 16.10pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$19.70 |
Change
0.520 ( 2.59 %) |
||||
| Open | High | Low | Volume | ||
| $19.50 | $19.84 | $19.28 | 87628 | ||
| Last updated 15.59pm 03/05/2024 ? | |||||
| NEU (ASX) Chart |